{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:07:41Z","timestamp":1767139661692,"version":"build-2238731810"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00277-025-06516-6","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T03:04:15Z","timestamp":1753153455000},"page":"3693-3702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation of the Spanish version of the EORTC QLQ-CML24 questionnaire for assessment of health-related quality of life in patients with chronic myeloid leukemia"],"prefix":"10.1007","volume":"104","author":[{"given":"Elisa","family":"Lopez-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soledad","family":"de Linares-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6329-8770","authenticated-orcid":false,"given":"Maria Nieves","family":"Perez-Marfil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio","family":"Vera-Go\u00f1i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Anguita-Arance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"del Carmen Fern\u00e1ndez-Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jose","family":"Ram\u00edrez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Concepci\u00f3n","family":"Ruiz-Nu\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Gonz\u00e1lez-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Ferrer-Chaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Avellaneda-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4081-3050","authenticated-orcid":false,"given":"Jose Manuel","family":"Puerta-Puerta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"6","key":"6516_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ajh.25792","volume":"95","author":"E Jabbour","year":"2020","unstructured":"Jabbour E, Kantarjian H (2020) Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring. Am J Hematol 95(6):691\u2013709. https:\/\/doi.org\/10.1002\/ajh.25792","journal-title":"Am J Hematol"},{"issue":"6","key":"6516_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11899-021-00656-y","volume":"16","author":"KL Schoenbeck","year":"2021","unstructured":"Schoenbeck KL, Flynn KE (2021) Health-Related quality of life of patients with chronic myeloid leukemia as measured by Patient-Reported outcomes: current state and future directions. Curr Hematol Malig Rep 16(6):491\u2013499. https:\/\/doi.org\/10.1007\/s11899-021-00656-y","journal-title":"Curr Hematol Malig Rep"},{"issue":"20","key":"6516_CR3","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1200\/JCO.2015.64.8899","volume":"34","author":"JE Cortes","year":"2016","unstructured":"Cortes JE, Saglio G, Kantarjian HM et al (2016) Final 5-Year study results of DASISION: the dasatinib versus Imatinib study in Treatment-Naive chronic myeloid leukemia patients trial. J Clin Oncol 34(20):2333\u20132340. https:\/\/doi.org\/10.1200\/JCO.2015.64.8899","journal-title":"J Clin Oncol"},{"key":"6516_CR4","doi-asserted-by":"publisher","unstructured":"Haguet H, Graux C, Mullier F et al (2020) Long-Term survival, vascular occlusive events and efficacy biomarkers of First-Line treatment of CML: A Meta-Analysis. Cancers (Basel) 12(5). https:\/\/doi.org\/10.3390\/cancers12051242","DOI":"10.3390\/cancers12051242"},{"key":"6516_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1182\/blood-2018-99-110128","volume":"132","author":"S O\u2019Brien","year":"2018","unstructured":"O\u2019Brien S, Cork L, Bandeira V et al (2018) Spirit 2: final 5 year analysis of the UK National Cancer research Institute randomized study comparing Imatinib with dasatinib in patients with newly diagnosed chronic phase CML. Blood 132:457\u2013457. https:\/\/doi.org\/10.1182\/blood-2018-99-110128","journal-title":"Blood"},{"key":"6516_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fonc.2019.00603","volume":"9","author":"V Garcia-Gutierrez","year":"2019","unstructured":"Garcia-Gutierrez V, Hernandez-Boluda JC (2019) Tyrosine kinase inhibitors available for chronic myeloid leukemia: efficacy and safety. Front Oncol 9:603. https:\/\/doi.org\/10.3389\/fonc.2019.00603","journal-title":"Front Oncol"},{"key":"6516_CR7","doi-asserted-by":"publisher","first-page":"1206893","DOI":"10.3389\/fphar.2023.1206893","volume":"14","author":"A Blanco Sanchez","year":"2023","unstructured":"Blanco Sanchez A, Gil Manso R, Carreno-Tarragona G et al (2023) Multidisciplinary management in chronic myeloid leukemia improves cardiovascular risk measured by SCORE. Front Pharmacol 14:1206893. https:\/\/doi.org\/10.3389\/fphar.2023.1206893","journal-title":"Front Pharmacol"},{"issue":"2","key":"6516_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41375-019-0563-0","volume":"34","author":"F Efficace","year":"2020","unstructured":"Efficace F, Stagno F, Iurlo A et al (2020) Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus Imatinib therapy. Leukemia 34(2):488\u2013498. https:\/\/doi.org\/10.1038\/s41375-019-0563-0","journal-title":"Leukemia"},{"key":"6516_CR9","doi-asserted-by":"publisher","first-page":"204062072412596","DOI":"10.1177\/20406207241259678","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Kuang P, Zhu H et al (2024) Successful maintenance of a sustained molecular response in CML patients receiving low-dose tyrosine kinase inhibitors. Ther Adv Hematol 15:20406207241259678. https:\/\/doi.org\/10.1177\/20406207241259678","journal-title":"Ther Adv Hematol"},{"issue":"16","key":"6516_CR10","doi-asserted-by":"publisher","first-page":"17239","DOI":"10.1002\/cam4.6296","volume":"12","author":"Y Chen","year":"2023","unstructured":"Chen Y, Xu N, Yang Y et al (2023) Quality-of-life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemia. Cancer Med 12(16):17239\u201317252. https:\/\/doi.org\/10.1002\/cam4.6296","journal-title":"Cancer Med"},{"issue":"24","key":"6516_CR11","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1182\/bloodadvances.2019000865","volume":"3","author":"M Baccarani","year":"2019","unstructured":"Baccarani M, Abruzzese E, Accurso V et al (2019) Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. Blood Adv 3(24):4280\u20134290. https:\/\/doi.org\/10.1182\/bloodadvances.2019000865","journal-title":"Blood Adv"},{"issue":"8","key":"6516_CR12","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1038\/s41375-020-0867-0","volume":"34","author":"G Sharf","year":"2020","unstructured":"Sharf G, Marin C, Bradley JA et al (2020) Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs. Leukemia 34(8):2102\u20132112. https:\/\/doi.org\/10.1038\/s41375-020-0867-0","journal-title":"Leukemia"},{"issue":"5","key":"6516_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European organization for research and treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365\u2013376. https:\/\/doi.org\/10.1093\/jnci\/85.5.365","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"6516_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s11136-013-0523-5","volume":"23","author":"F Efficace","year":"2014","unstructured":"Efficace F, Baccarani M, Breccia M et al (2014) International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24. Qual Life Res 23(3):825\u2013836. https:\/\/doi.org\/10.1007\/s11136-013-0523-5","journal-title":"Qual Life Res"},{"issue":"3","key":"6516_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/10428194.2020.1838509","volume":"62","author":"F Efficace","year":"2021","unstructured":"Efficace F, Iurlo A, Patriarca A et al (2021) Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia. Leuk Lymphoma 62(3):669\u2013678. https:\/\/doi.org\/10.1080\/10428194.2020.1838509","journal-title":"Leuk Lymphoma"},{"key":"6516_CR16","unstructured":"EORTC quality of life group translation procedure. 3rd ed. EORTC Quality of Life Group Publication, Brussels (2009) (ISBN 978-2-930064-38-3)"},{"issue":"6","key":"6516_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr., Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473\u2013483","journal-title":"Med Care"},{"issue":"6","key":"6516_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361\u2013370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"6516_CR19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/jts.20271","volume":"20","author":"L Campbell-Sills","year":"2007","unstructured":"Campbell-Sills L, Stein MB (2007) Psychometric analysis and refinement of the Connor-davidson resilience scale (CD-RISC): validation of a 10-item measure of resilience. J Trauma Stress 20(6):1019\u20131028. https:\/\/doi.org\/10.1002\/jts.20271","journal-title":"J Trauma Stress"},{"issue":"4","key":"6516_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF01593882","volume":"4","author":"CA McHorney","year":"1995","unstructured":"McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4(4):293\u2013307. https:\/\/doi.org\/10.1007\/BF01593882","journal-title":"Qual Life Res"},{"key":"6516_CR21","volume-title":"Psychometric theory","author":"J Nunnally","year":"1994","unstructured":"Nunnally J, Bernstein L (1994) Psychometric theory. McGraw-Hill Higher, INC, New York"},{"key":"6516_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF02291575","volume":"39","author":"HF Kaiser","year":"1974","unstructured":"Kaiser HF (1974) An index of factorial simplicity. Psychometrika 39:31\u201336","journal-title":"Psychometrika"},{"key":"6516_CR23","first-page":"337","volume":"38","author":"MS Bartlett","year":"1951","unstructured":"Bartlett MS (1951) The effect of standardization on a Chi-square approximation in factor analysis. Biometrika 38:337\u2013344","journal-title":"Biometrika"},{"key":"6516_CR24","volume-title":"IBM SPSS Amos 22. User\u2019s guide","author":"JL Arbuckle","year":"2013","unstructured":"Arbuckle JL (2013) IBM SPSS Amos 22. User\u2019s guide. Amos Development Corporation, Chicago, IL"},{"key":"6516_CR25","doi-asserted-by":"crossref","unstructured":"Byrne B (2016) Structural equation modeling with AMOS (3a ed.). New York, NY: Routledge","DOI":"10.4324\/9781315757421"},{"key":"6516_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1037\/0033-2909.105.3.430","volume":"105","author":"S Mulaik","year":"1989","unstructured":"Mulaik S, James L, Alstine J et al (1989) Evaluation of Goodness-of-Fit indices for structural equation models. Psychol Bull 105:430\u2013445. https:\/\/doi.org\/10.1037\/0033-2909.105.3.430","journal-title":"Psychol Bull"},{"issue":"3","key":"6516_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","volume":"18","author":"H Akoglu","year":"2018","unstructured":"Akoglu H (2018) User\u2019s guide to correlation coefficients. Turk J Emerg Med 18(3):91\u201393. https:\/\/doi.org\/10.1016\/j.tjem.2018.08.001","journal-title":"Turk J Emerg Med"},{"issue":"7","key":"6516_CR28","doi-asserted-by":"publisher","first-page":"e94568","DOI":"10.5812\/ijcm.94568","volume":"12","author":"A Tavoli","year":"2019","unstructured":"Tavoli A, Tavoli Z, Montazeri A (2019) The relationship between emotional functioning of the EORTC QLQ-C30 and A measure of anxiety and depression (HADS) in Cancer patients. Int J Cancer Manag 12(7):e94568","journal-title":"Int J Cancer Manag"},{"issue":"12","key":"6516_CR29","doi-asserted-by":"publisher","first-page":"e0243357","DOI":"10.1371\/journal.pone.0243357","volume":"15","author":"Y Wondie","year":"2020","unstructured":"Wondie Y, Mehnert A, Hinz A (2020) The hospital anxiety and depression scale (HADS) applied to Ethiopian cancer patients. PLoS ONE 15(12):e0243357. https:\/\/doi.org\/10.1371\/journal.pone.0243357","journal-title":"PLoS ONE"},{"issue":"17","key":"6516_CR30","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1182\/blood-2011-04-347575","volume":"118","author":"F Efficace","year":"2011","unstructured":"Efficace F, Baccarani M, Breccia M et al (2011) Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with Imatinib compared with the general population. Blood 118(17):4554\u20134560. https:\/\/doi.org\/10.1182\/blood-2011-04-347575","journal-title":"Blood"},{"issue":"3","key":"6516_CR31","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s11136-021-02952-9","volume":"31","author":"CTT Nguyen","year":"2022","unstructured":"Nguyen CTT, Nguyen BT, Nguyen TTT et al (2022) Quality of life among chronic myeloid leukemia patients in the second-line treatment with nilotinib and influential factors. Qual Life Res 31(3):733\u2013743. https:\/\/doi.org\/10.1007\/s11136-021-02952-9","journal-title":"Qual Life Res"},{"key":"6516_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejca.2018.11.024","volume":"107","author":"S Nolte","year":"2019","unstructured":"Nolte S, Liegl G, Petersen MA et al (2019) General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the unites States. Eur J Cancer 107:153\u2013163. https:\/\/doi.org\/10.1016\/j.ejca.2018.11.024","journal-title":"Eur J Cancer"}],"updated-by":[{"DOI":"10.1007\/s00277-025-06603-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000}}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06516-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06516-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06516-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T20:02:41Z","timestamp":1763236961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06516-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6516"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06516-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00277-025-06603-8","URL":"https:\/\/doi.org\/10.1007\/s00277-025-06603-8","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Provincial Ethics Committee of Granada, and all patients gave their informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}